American Financial Network Advisory Services’s Integra LifeSciences IART Stock Holding History

American Financial Network Advisory Services’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-88	Closed	-$4K	–	357
2017 Q4	$4K	Hold	88	–	–	﹤0.01%	576
2017 Q3	$4K	Buy	+88	New	+$4.52K	﹤0.01%	609

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Financial Network Advisory Services's IART Position: Q1 2018 in Review

American Financial Network Advisory Services sold out of Integra LifeSciences (IART) in Q1 2018, closing a stake of 88 shares — an estimated $4K sold.

American Financial Network Advisory Services first reported a position in IART in Q3 2017 and held it in 2 quarters. The position peaked at $4K in Q4 2017. 235 funds tracked by Wall St. Rank hold IART as of Q1 2018.

American Financial Network Advisory Services reported no remaining Integra LifeSciences position as of Q1 2018 after selling out during the quarter.
American Financial Network Advisory Services sold 88 Integra LifeSciences shares in Q1 2018, an estimated $4K.
American Financial Network Advisory Services first reported a position in Integra LifeSciences in Q3 2017 and held it in 2 quarters.
American Financial Network Advisory Services's Integra LifeSciences position peaked at $4K in Q4 2017.
235 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2018.

Based on American Financial Network Advisory Services's 13F filing for Q1 2018, filed 15 May 2018.